Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia.

ABSTRACT:

Purpose of review

The past decade in LGL leukemia research has seen increased pairing of clinical data with molecular markers, shedding new insights on LGL leukemia pathogenesis and heterogeneity. This review summarizes the current standard of care of LGL leukemia, updates from clinical trials, and our congruent improved understanding of LGL pathogenesis.

Recent findings

Various clinical reports have identified associations between stem, bone marrow, and solid organ transplants and incidence of LGL leukemia. There is also a potential for underdiagnosis of LGL leukemia within the rheumatoid arthritis patient population, emphasizing our need for continued study. Preliminary results from the BNZ-1 clinical trial, which targets IL-15 along with IL-2 and IL-9 signaling pathways,

SUBMITTER: Cheon H 

PROVIDER: S-EPMC7234906 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature